2172 — Microport NeuroTech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual income statement for Microport NeuroTech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	184	222	383	547	666
Cost of Revenue
Gross Profit	146	165	298	393	512
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	130	166	298	426	476
Operating Profit	54.1	55.9	84.7	122	190
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	52.4	51.4	31.9	-4.33	162
Provision for Income Taxes
Net Income After Taxes	47	45.3	24.2	-24.7	135
Minority Interest
Net Income Before Extraordinary Items
Net Income	47	45.3	24.2	-21.8	146
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	47	45.3	24.2	-21.8	146
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.081	0.078	0.076	-0.014	0.293
Dividends per Share